Thesis defense 🌻 #LearningJourney #sciencefantasy #explore

New ⁦National Comprehensive Cancer Network (NCCN)⁩ guidelines for Breast/Ovarian/Pancreatic Cancer Genetics posted at nccn.org/professionals/… New recommendation that #PancreaticCancer screening be “considered” for all BRCA2 and ATM pathogenic variant carriers by age 50, even without known family history

Where nature meets life 🕊️ South Annapurna and Macchapuchre (fishtail) mountains. Answering the nature's call 😊 #whereibelong #PositiveEnergy #science #research

BREAKING NEWS The 2024 #NobelPrize in Physiology or Medicine has been awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.

“The call from Stockholm is mythic in the world of science.” New medicine laureate Gary Ruvkun has received a prank call or two in the past, but today’s was genuine. We talked to him minutes after he heard the news of his #NobelPrize.

Congratulations 🎉🎊 Victor Ambros, Phd and Gary Ruvkun, phd for winning the Nobel Prize in Physiology and Medicine 2024 "For the discovery of microRNA and its role in post-transcriptional gene regulation" A new tip of the iceberg in science (molecular biology)

BREAKING NEWS The Royal Swedish Academy of Sciences has decided to award the 2024 #NobelPrize in Chemistry with one half to David Baker “for computational protein design” and the other half jointly to Demis Hassabis and John M. Jumper “for protein structure prediction.”

This year's #RueschSymposium Thomas R. Schafer Memorial Lecture features Dr. Anirban Maitra (Anirban Maitra) of MD Anderson Cancer Center on November 22, 2024, at 1:20 p.m. EST. Learn more and register today. bit.ly/Ruesch2024. Georgetown Lombardi MedStar Georgetown

In the not-too-distant future, a pancreatic cancer vaccine specific to the mutations in a patient’s cancer may reduce their risk of recurrence. Learn about the latest research: brnw.ch/21wOSOL #PancreaticCancer #EndCancer

Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial ⁦Journal of Clinical Oncology⁩ The median OS was 29.5 months (27.5-32.1) for all patients, 28.4 months in the gemcitabine group and 31.6 months in the GemCap group ascopubs.org/doi/10.1200/JC…

"Success doesn’t come from what you do occasionally, it comes from what you do consistently." - Marie Forleo #mondaymotivation

healthimaging.com/topics/medical…

May the magic of Christmas fill your home with joy, your heart with love, and your life with laughter. Wishing you a season of blessings, peace, and cherished moments with your loved ones. Merry Christmas! 🎄🎁🎊 #MerryChristmas #scientificcommunitie #pancan

Today 28 people will be diagnosed with pancreatic cancer only 21 will still be alive by the end of Jan 1 in 4 people die within a month of diagnosis and this figure has barely changed in the last 50 years this has to change hopefully 2025 see a breakthrough #sethslegacy

Rejection is normal; keep moving forward. Your career is bigger than any one grant or paper rejection. Be persistent. Try again. #AcademicChatter

His journey is a testament to the power of passion and perseverance 🌻

Don’t be afraid to start over — this time you’re not starting from scratch, you’re starting from experience.

Early detection and targeted therapies are crucial. Highlighting Eileen Carpenter, MD, PhD. Her personal and professional mission. U-M Rogel Cancer Center timofran Lyssiotis Lab PascaLab rogelcancercenter.org/illuminate/tac…